Boyle Heights Cardiovascular Medical Group INC
Boyle Heights Cardiovascular Medical Group INC was paid $3.63M by Medicaid between Jan 2018 and Dec 2024, across 29 billing codes. Its largest line is 93306, Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete — 34% of everything it billed.
LOS ANGELES, CA 90033
Next to other Interventional Cardiology Physician providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,352 | $251K | |
| 2019 | 6,554 | $343K | |
| 2020 | 5,283 | $332K | |
| 2021 | 7,266 | $488K | |
| 2022 | 9,784 | $664K | |
| 2023 | 13,954 | $926K | |
| 2024incomplete | 12,374 | $627K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 34% | 11,697 | 11,488 | $1.25M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 17,925 | 17,715 | $543K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 13% | 7,783 | 3,915 | $457K |
| 99223 | Prolong inpt eval add15 m | 8.8% | 3,593 | 3,491 | $319K |
| 99205 | Prolong outpt/office vis | 5.1% | 2,652 | 2,650 | $186K |
| 93351 | 4.0% | 802 | 762 | $144K | |
| 93880 | 3.9% | 1,995 | 1,990 | $143K | |
| 93000 | 2.9% | 6,412 | 6,403 | $106K | |
| 93224 | 2.5% | 1,164 | 1,104 | $91K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 2.4% | 391 | 389 | $89K |
| 93978 | 2.0% | 1,182 | 1,178 | $71K | |
| 93925 | 1.9% | 1,138 | 1,137 | $68K |
17 more codes
| 93923 | 1.1% | 1,168 | $41K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 374 | $24K |
| 93015 | <1% | 452 | $24K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 318 | $17K |
| A9505 | Thallium tl-201 thallous chloride, diagnostic, per millicurie | <1% | 149 | $11K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 50 | $10K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 184 | $10K |
| 99152 | <1% | 313 | $7K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 234 | $5K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 53 | $5K |
| 93458 | <1% | 24 | $4K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 253 | $3K |
| 93297 | <1% | 103 | $2K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 51 | $278.67 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 42 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 20 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 45 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| KP Pharmacy & Medical Supplies LLC | Seattle, WA | $2.33M |
| Eye Q Optometry INC | Westminster, CA | $235K |
| Spectrum Eye Care | Houston, TX | $159K |
| The 5TH Element Medical Practice PC | Albuquerque, NM | $107K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.